Discover 320 paid clinical trials in Santa Fe, New Mexico. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 320
Active & Responsive
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
for
Chronic Granulomatous Disease (CGD)
1 location in Santa Fe
Sponsor: Ensoma
Sex: All
Age: 0+
Code: NCT06605378
Recruiting
Active & Responsive
Caris Biorepository Research Protocol
for
Cancer, Early Detection of Cancer, Minimal Residual Disease
1 location in Santa Fe
Sponsor: Caris Science, Inc.
Sex: All
Age: 18+
Code: NCT01499394
Recruiting
Active & ResponsiveNew
A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer.
for
Locally Advanced Pancreatic Adenocarcinoma,
1 location in Santa Fe
Sponsor: Xerient Pharma
Sex: All
Age: 18+
Code: NCT07157033
Phase1, Phase2, Recruiting
Active & Responsive
RA-PRO PRAGMATIC TRIAL
for
Rheumatoid Arthritis
1 location in Santa Fe
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT04692493
Phase3, Recruiting
Active & Responsive
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus
for
Systemic Lupus Erythematosus
1 location in Santa Fe
Sponsor: AbbVie
Sex: All
Age: 18 - 63
Code: NCT05843643
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & ResponsiveNew
Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
for
Phantom Limb Syndrome With Pain
1 location in Albuquerque
Sponsor: The Ketamine Research Foundation
Sex: All
Age: 18 - 65
Code: NCT07276542
Phase2, Phase3, Recruiting
Active & Responsive
A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
for
Prostate Cancer,
1 location in Albuquerque
Sponsor: Astellas Pharma Global Development, Inc.
Sex: Male
Age: 18+
Code: NCT07005154
Phase2, Recruiting
Active & Responsive
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
for
Triple Negative Breast Neoplasms
1 location in Albuquerque
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06841354
Phase3, Recruiting
Active & Responsive
DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)
for
Breast Cancer
1 location in Albuquerque
Sponsor: Criterium, Inc.
Sex: All
Age: 0+
Code: NCT04567420
Phase2, Recruiting
Active & Responsive
A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder